JPMorgan analyst Samik Chatterjee raised the firm’s price target on Celestica (CLS) to $388 from $305 and keeps an Overweight rating on the shares. The firm upped estimates post the Q3 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLS:
- Celestica price target raised to $357 from $220 at Barclays
- Celestica’s Manufacturing Shifts: Navigating Risks and Financial Impacts
- Celestica Reports Strong Q3 2025 Results and Raises Outlook
- Laurette T. Koellner Rejoins Celestica’s Board of Directors
- Celestica appoints Laurette Koellner to board of directors
